What is she best known for?
The fields of study she is best known for:
Vijaya Ramesh mainly focuses on Genetics, Tumor suppressor gene, Molecular biology, Carcinogenesis and Gene.
Her research integrates issues of Merlin, Mutation, Ectoderm, Mesoderm and Gene targeting in her study of Tumor suppressor gene.
The various areas that she examines in her Merlin study include Moesin, COS cells and Filopodia.
Her Carcinogenesis research includes themes of Cancer research and Neurofibromatosis.
Her work is dedicated to discovering how Cancer research, TSC2 are connected with Cell cycle and other disciplines.
Vijaya Ramesh has researched Exon in several fields, including Locus and Loss of heterozygosity.
Her most cited work include:
- Reversal of learning deficits in a Tsc2 +/− mouse model of tuberous sclerosis (675 citations)
- The FERM domain: A unique module involved in the linkage of cytoplasmic proteins to the membrane (461 citations)
- NHE-RF, a Regulatory Cofactor for Na+-H+Exchange, Is a Common Interactor for Merlin and ERM (MERM) Proteins (235 citations)
What are the main themes of her work throughout her whole career to date?
Her main research concerns Genetics, Merlin, Molecular biology, Cell biology and Gene.
Her Merlin research also works with subjects such as
- Pathology that connect with fields like TSC1 and Human brain,
- Stop codon most often made with reference to Frameshift mutation.
Vijaya Ramesh combines subjects such as genomic DNA, Protein subunit, RNA and Coding region with her study of Molecular biology.
Her Cell biology research incorporates themes from Moesin, Actin-binding protein, Actin cytoskeleton, Immunoprecipitation and Radixin.
Her studies examine the connections between Moesin and genetics, as well as such issues in Actin, with regards to PDZ domain.
Her Neurofibromatosis study combines topics from a wide range of disciplines, such as Carcinogenesis, Cancer research and Meningioma.
She most often published in these fields:
- Genetics (35.04%)
- Merlin (23.08%)
- Molecular biology (24.79%)
What were the highlights of her more recent work (between 2012-2021)?
- Cancer research (19.66%)
- Schwannomatosis (6.84%)
- mTORC1 (8.55%)
In recent papers she was focusing on the following fields of study:
Cancer research, Schwannomatosis, mTORC1, Neurofibromatosis and Kinome are her primary areas of study.
The concepts of her Cancer research study are interwoven with issues in Tuberous sclerosis, Genetic enhancement, Tumor suppressor gene and TSC2, PI3K/AKT/mTOR pathway.
Her TSC2 study is concerned with the larger field of Genetics.
Particularly relevant to TSC1 is her body of work in Genetics.
Her Neurofibromatosis type 2 study, which is part of a larger body of work in Neurofibromatosis, is frequently linked to Foundation, bridging the gap between disciplines.
Her Neurofibromatosis type 2 research includes elements of Merlin and Clinical trial, Bioinformatics.
Between 2012 and 2021, her most popular works were:
- A high-throughput kinome screen reveals serum/glucocorticoid-regulated kinase 1 as a therapeutic target for NF2-deficient meningiomas (28 citations)
- CTF meeting 2012: Translation of the basic understanding of the biology and genetics of NF1, NF2, and schwannomatosis toward the development of effective therapies (14 citations)
- Survival benefit and phenotypic improvement by hamartin gene therapy in a tuberous sclerosis mouse brain model. (11 citations)
In her most recent research, the most cited papers focused on:
Her primary scientific interests are in TSC1, mTORC1, Cancer research, Kinome and TSC2.
Her studies in TSC1 integrate themes in fields like Transcriptome, Ubiquitin ligase and RHEB.
Her mTORC1 study contributes to a more complete understanding of Cell biology.
Her Cancer research research is multidisciplinary, relying on both mTORC2, Immediate early protein, Molecular biology, Signal transduction and Meningioma.
Her research in Kinome intersects with topics in Proto-oncogene tyrosine-protein kinase Src, Receptor tyrosine kinase, Erythropoietin-producing hepatocellular receptor, Tumor suppressor gene and Tumor progression.
Her study on TSC2 is covered under Genetics.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
